Protocol No.: N0577

Title
Phase III Intergroup Study of Temozolomide versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV chemotherapy in Patients with 1p/19q Codeleted Anaplastic Glioma
Principal Investigator
Kolodney, Joanna
Phase
III (Cancer Control)
Age Group
Adult
Applicable Disease Site
Brain Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sylvia McEwuen, RN, CCRC
Study Coordinator/Research Nurse
Phone: +1 304-293-1683

View on ClinicalTrials.gov